NiKang Therapeutics has concluded the first cohort dosing in the open-label Phase I trial of NKT3964 as a monotherapy for ...

Burchfield, MD, and other participants discussed their experiences with the frontline combination regimens for advanced renal ...

Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today an ...

Your wounds may heal slower due to hidden factors like stress, timing, and microbiome changes. Learn how to support your body ...

During a live event, Alexander I. Spira, MD, PhD, and participants discuss efficacy, adverse events, and sequencing of EGFR-mutated NSCLC treatments.

Phase 2 trial results support further development of neoadjuvant nivolumab-based CIT and adaptive de-escalation of CRT in patients with locoregionally advanced HNSCC, according to researchers.

Q4 2024 Earnings Call Transcript March 10, 2025 Operator: Good morning, ladies and gentlemen, and thank you for standing by.

Retired Edwards Lifesciences Engineering SVP Ming Wu answers questions about nitinol manufacturing, testing and medical ...

Best sleep supplements to boost your chances of getting a good night’s kip - To get your eight hours or more, you may need to ...

Zúñiga believes that interventions that target LDHB or related metabolic pathways could be explored as a way to counteract ...

TNBC, aggressive and lacking key receptors, complicates treatment, impacting prognosis and requiring specialized approaches.

This valuable study provides new insights into the synchronization of ripple oscillations in the hippocampus, both within and across hemispheres. Using carefully designed statistical methods, it ...